エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
Second Edition BOGP (0)
Care Delivery/ Care pathway
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Capacity and capabilities for engagement
Clinical study phase I